The Race for a Cure: an oral COVID-19 vaccine
Last week, Cells4Life’s sister company, Stabilitech, featured on ITV’s Tonight programme “The Race for a Cure: Making Britain Safer”. This episode looks at making a COVID-19 vaccine. You can watch the full interview by watching the video...
“How cord tissue changed my son’s life”
A 5-year-old boy with Autism Spectrum Disorder (ASD) has made significant progress after receiving stem cell therapy using umbilical cord tissue. Gage was diagnosed with ASD at just two years old after there were some indications that there may be a problem –...
Stabilitech, Recognised by WHO as COVID-19 Vaccine Developer
The sister company of Cells4Life, Stabilitech Biopharma, have been formally recognised by the World Health Organisation (WHO) as an official vaccine developer. Stabilitech board member Dr Jeff Drew, who is also the co-founder of Cells4Life, noted: “The WHO is a...
Study: Pregnancy Not Increasing Severe COVID-19 Risk
According to the first large-scale study of its kind, pregnant women are at no greater risk of being admitted to hospital with severe coronavirus symptoms than other women. The study examined more than 420 expectant mothers who were admitted to hospital with critical...
Stabilitech Joins Race for COVID-19 Vaccine
The sister company of Cells4Life – Stabilitech – has joined the race to create a vaccine for the coronavirus which has put the country into lockdown and is currently raising £6 million in funding to finance the next crucial stage of development. Stabilitech, a UK...
Recent Posts
-
Umbilical Cord Stem Cell Eye Drops Could Offer Relief From Dry Eye
-
First Cord Blood Treatment for Cerebral Palsy Performed in Australia
-
Could Cord Tissue Stem Cells Help Manage Type 2 Diabetes?
-
Early Insights Into Placenta Stem Cell Therapy for Multiple Sclerosis
-
Study Shows Improvement From Placenta Stem Cell Injections for Knee Osteoarthritis
